| Literature DB >> 30087685 |
Lee A Hadwiger1, Kiwamu Tanaka1.
Abstract
Over the last decades, medical research has utilized DNA altering procedures in cancer treatments with the objective of killing cells or suppressing cell proliferation. Simultaneous research related to enhancing disease resistance in plants reported that alterations in DNA can enhance defense responses. These two opposite perspectives have in common their effects on the center for gene transcription, the nuclear chromatin. A review of selected research from both anticancer- and plant defense-related research provides examples of some specific DNA altering actions: DNA helical distortion, DNA intercalation, DNA base substitution, DNA single cleavage by DNases, DNA alkylation/methylation, and DNA binding/exclusion. The actions of the pertinent agents are compared, and their proposed modes of action are described in this study. Many of the DNA specific agents affecting resistance responses in plants, e.g., the model system using pea endocarp tissue, are indeed anticancer agents. The tumor cell death or growth suppression in cancer cells following high level treatments may be accompanied with chromatin distortions. Likewise, in plants, DNA-specific agents activate enhanced expression of many genes including defense genes, probably due to the chromatin alterations resulting from the agents. Here, we propose a hypothesis that DNA damage and chromatin structural changes are central mechanisms in initiating defense gene transcription during the nonhost resistance response in plants.Entities:
Keywords: DNA conformation; DNA damage; anti-cancer agents; chromatin structural changes; nonhost resistance
Year: 2018 PMID: 30087685 PMCID: PMC6066612 DOI: 10.3389/fpls.2018.01056
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Action modes of some DNA-specific agents.
| DNA specific agent | DNA affinity/sequence specificity/action mode | Reference |
|---|---|---|
| Mithramycin | GC-rich seq.- displaces Sp1 transcription factor, minor groove binding | |
| Ethidium bromide | DNA intercalator | |
| Acrid. orange | DNA intercalator, DNA single strand binder | |
| Chitosan | Chitosan heptamer fits in DNA minor groove | |
| Distamycin A | Inhibitor of helicase and topoisomerase I-II, minor groove binder, stimulates Pol II pause site | |
| Neomycin | Stabilizes DNA triplex TAT | |
| Daunomycin | Intercalates Adj.G/C bp on 5’side of A/T bp; Induces DNA unwind; Evicts histone from minor groove | |
| Spermine | A-DNA backbone bridging major and minor grooves | |
| Hoechst 33258 | AT tract-topoisomerase poison; DNA minor groove binding and intercalates DNA bases | |
| DAPI | AT-specific; minor groove binding; not topo I poison |
Pisatin production in pea endocarp tissue 24 h after treatment with DNA-specific compounds, capable of DNA intercalation or minor groove localization.
| Agent appl. mg/mL -> | 1.0 | 0.5 | 0.25 | 0.12 | 0.06 | 0.03 | 0.015 |
| Mithramycin | 258.5 | 209.6 | 264.9 | 283.8 | 146.0 | 3.2 | 0.0 |
| Ethidium br. | 18.2 | 43.1 | 130.9 | 104.9 | 97.2 | 131.7 | 131.6 |
| Acrid. orange | 104.3 | 14.9 | 9.7 | 9.8 | 9.0 | 6.0 | 8.0 |
| Chitosan hep. | 50.4 | 95.9 | 8.4 | 25.2 | 19.4 | 7.6 | – |
| Distamycin A | 73.3 | 40.5 | 30.3 | 22.9 | 14.3 | 6.9 | 3.7 |
| Neomycin | 62.1 | 5.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Daunomycin | 44.5 | 44.3 | 52.1 | 52.2 | 4.7 | 4.9 | 2.1 |
| Spermine | 22.9 | 37.3 | 15.6 | 17.5 | 5.6 | 9.5 | – |
| Hoechst33258 | 24.1 | 14.3 | 17.8 | 8.0 | 0.0 | 13.9 | 0.0 |
| DAPI | 10.5 | 7.5 | 8.9 | 8.4 | 4.7 | 4.3 | 5.5 |